Written by Zane McNeill, Civil Rights & Health Equity Legal Fellow at L4GG — approved by the FDA 25 years ago and used in nearly two-thirds of U.S. abortions, mifepristone is now under coordinated attack from anti-abortion states and the Trump administration, which is using agency review as a potential backdoor to restrict or ban the medication nationwide.

